PMID: 18215767

Deber CM, Cheung JC, Rath A
Defining the defect in F508 del CFTR: a soluble problem?
Chem Biol. 2008 Jan;15(1):3-4., [PubMed]
Sentences
No. Mutations Sentence Comment
2 ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215767:2:199
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215767:2:220
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215767:2:205
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215767:2:226
status: NEW
view ABCC7 p.Gln637Arg details
In this issue of Chemistry & Biology, Pissarra et al. (2008) show that partial rescue of the trafficking and gating defects of full-length CFTR occurs in vivo upon recapitulation of the solubilizing F494N/Q637R or F428S/F494N/Q637R substitutions in cis with F508 del. Login to comment
18 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 18215767:18:129
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215767:18:122
status: NEW
view ABCC7 p.Gly550Glu details
ABCC7 p.Arg555Lys
X
ABCC7 p.Arg555Lys 18215767:18:140
status: NEW
view ABCC7 p.Arg555Lys details
The first human F508 del-NBD1 structure obtained carried seven additional mutations, three of which (suppressor mutations G550E, R553Q, and R555K) were known to rescue the F508 del-CFTR defect (Chang et al., 1999; DeCarvalho et al., 2002; Teem et al., 1996). Login to comment
19 ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215767:19:103
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215767:19:124
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215767:19:109
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215767:19:131
status: NEW
view ABCC7 p.Gln637Arg details
Two F508 del-NBD1 structures lacking the suppressor mutations but retaining certain other alterations (F494N/Q637R or F428S/F494N/ Q637R) necessary for protein solubility subsequently became available (Lewis et al., 2005, http://www.pdb.org). Login to comment
23 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215767:23:201
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215767:23:186
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215767:23:207
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215767:23:192
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215767:23:214
status: NEW
view ABCC7 p.Gln637Arg details
To address this question, Pissarra et al. (2008) report in this issue on the trafficking in mammalian cell lines of full-length CFTR proteins carrying wt, F508 del, or F508 del with the F494N/Q637R or F429S/F494N/ Q637R replacements. Login to comment
25 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215767:25:66
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215767:25:73
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215767:25:79
status: NEW
view ABCC7 p.Gln637Arg details
Strikingly, the solubilizing mutations, notably the triple mutant F429S/ F494N/Q637R, appeared to promote some N-glycan processing in F508 del CFTR, to produce Band C, along with bands of MW intermediate between those of Band B and Band C, suggesting that these replacements partially rescue the trafficking defect. Login to comment